Medicago and GlaxoSmithKline (GSK) have announced positive efficacy and safety results from the global Phase III placebo-controlled efficacy study of Medicago’s plant-based COVID-19 vaccine candidate …

With the emergence of the new Omicron variant bringing into question the effectiveness of current vaccines, scientists caution that viruses will continue to evolve. According …

The Joint Committee on Vaccination and Immunisation (JCVI) has responded to the emergence of the Omicron variant and updated its guidance, with immediate effect. A …

Travellers vaccinated with Bharat Biotech’s Covaxin will now be able to enter the UK, as the vaccine has been added to the approved list. This …

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced topline results from a Phase 3 randomized, controlled trial evaluating the efficacy and safety of …

Pfizer and BioNTech have announced that the Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the administration of the …

SK bioscience (SK) and GlaxoSmithKline plc (GSK) today announced the initiation of Phase 3 clinical study of SK’s COVID-19 vaccine candidate, GBP510, in combination with …